NCT01872832View on ClinicalTrials.gov

Single and Multiple Dose Study in Japanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

November 30, 2013

Conditions
Gout
Interventions
DRUG

RDEA3170 and Placebo

Trial Locations (1)

91206

Glendale

Sponsors
All Listed Sponsors
lead

Ardea Biosciences, Inc.

INDUSTRY

NCT01872832 - Single and Multiple Dose Study in Japanese Subjects | Biotech Hunter | Biotech Hunter